About The Webinar
Hemangiosarcoma is an aggressive tumour of vascular endothelial origin. In dogs it accounts for 45-51% of splenic tumours. The most common presentation is acute weakness or collapse and haemoabdomen. Treatment of canine splenic hemangiosarcoma involves a combination of surgery and chemotherapy in order to maximise survival times. In this webinar we discuss the diagnosis, clinical staging, treatment and prognosis for hemangiosarcoma of the spleen and other body locations in dogs and cats. We review traditional treatment options as well as discuss what's new in the medical treatment of hemangiosarcoma and what's likely around the corner for our veterinary patients.
